跳至主要内容
临床试验/NL-OMON51866
NL-OMON51866招募中不适用

Endoscopic mucosal Resection versus Endoscopic subMucosal dissection fOr removal of Visible lesions in Barrett*s Esophagus with early neoplasia: a randomized controlled trial - REMOVE RCT

Sint Antonius Ziekenhuis0 个研究点目标入组 84 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Patients age: >= 18 years
  • - Willingness to undergo both EMR or ESD
  • - Ability to provide written, informed consent (approved by IRB) and understand
  • the responsibilities of trial participation
  • - BE with a single visible lesion with absence of signs of submucosal invasion
  • on endoscopy, after evaluation by the adjudication committee.
  • - Minimum diameter of the lesion >=15mm (in either direction)

排除标准

  • - Patients with visible lesions with suspicion of submucosal invasion bases on
  • assessment of the adjudication committee
  • - History of esophageal surgery other than fundoplication
  • - History of esophageal ablation therapy or endoscopic resection
  • - Multiple visible lesions in the BE segment at baseline
  • - Uncontrolled coagulopathy with INR >2.0, thrombocytopenia with platelet
  • counts < 50,000
  • - Subject has a known history of unresolved drug or alcohol dependency that
  • would limit ability to comprehend or follow instructions related to informed
  • consent, post-treatment in-structions, or follow-up guidelines
  • - Life expectancy <2 years

研究者

相似试验

Endoscopic mucosal Resection versus Endoscopic... | 临床试验